FIDVAXI

Serial Number 79352877
Registration 7227043
700

Registration Progress

Application Filed
Sep 1, 2022
Under Examination
Approved for Publication
Sep 12, 2023
Published for Opposition
Sep 12, 2023
Registered
Nov 28, 2023

Trademark Image

FIDVAXI

Basic Information

Serial Number
79352877
Registration Number
7227043
Filing Date
September 1, 2022
Registration Date
November 28, 2023
Published for Opposition
September 12, 2023
Drawing Code
5

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 28, 2023
Registration
Registered
Classes
005

Rights Holder

Genexine, Inc.

03
Address
Magokjungang-ro, Gangseo-gu Seoul
(Magokdong, Bio Innovation Park) 172,
KR

Ownership History

Genexine, Inc.

Original Applicant
03
KR

Genexine, Inc.

Owner at Publication
03
KR

Genexine, Inc.

Original Registrant
03
KR

Legal Representation

Attorney
Leigh Ann Lindquist

USPTO Deadlines

Next Deadline
1581 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-11-28)
Due Date
November 28, 2029
Grace Period Ends
May 28, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

32 events
Date Code Type Description Documents
Feb 7, 2025 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Mar 26, 2024 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Mar 4, 2024 FIMP P FINAL DISPOSITION PROCESSED Loading...
Mar 4, 2024 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Feb 28, 2024 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Nov 28, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 28, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Sep 12, 2023 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Sep 12, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 12, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 23, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 23, 2023 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Aug 23, 2023 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Aug 4, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 6, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 6, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 6, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 13, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 13, 2023 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Jun 13, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 13, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 13, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jun 13, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Feb 2, 2023 RFNT P REFUSAL PROCESSED BY IB Loading...
Jan 12, 2023 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Jan 12, 2023 RFRR P REFUSAL PROCESSED BY MPU Loading...
Nov 3, 2022 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Nov 2, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 2, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 25, 2022 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Oct 21, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 20, 2022 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical products for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely, immunomodulators; viral vaccines; pharmaceutical preparations for the treatment of viral diseases; vaccines; vaccine preparations; pharmaceutical preparations and substances for use in gynecology; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical products for the treatment of viral and infectious diseases of cancer patients; biopharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; human vaccine preparations; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for suppressing tumors

Classification

International Classes
005